Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088866 · ClinicalTrials.gov registry record · Early Phase 1
Commercial Lidocaine Patch as a Treatment for Ear-ringing
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT02088866 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 30 participants.
The verdict
NCT02088866, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this investigation is to evaluate if topically applied lidocaine, in the form of lidocaine patches, reduces the burden of chronic subjective tinnitus in a consistent and measurable way.
Interventions
- DRUG Transdermal Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02088866
The ClinicalTrials.gov registry entry for NCT02088866 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdermal Lidocaine is the first listed.
NCT02088866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02088866 about?
NCT02088866 is a clinical study titled "Commercial Lidocaine Patch as a Treatment for Ear-ringing". The purpose of this investigation is to evaluate if topically applied lidocaine, in the form of lidocaine patches, reduces the burden of chronic subjective tinnitus in a consistent and measurable way.
What is the current status of trial NCT02088866?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2014-03. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02088866?
The interventions under investigation include: Transdermal Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02088866?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.